Theresa Janke
Fundador en 4D MOLECULAR THERAPEUTICS, INC. .
Cargos activos de Theresa Janke
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
4D MOLECULAR THERAPEUTICS, INC. | Oficial de Recursos Humanos | 12/09/2013 | - |
Fundador | 12/09/2013 | - | |
Director de Operaciones | 01/04/2018 | 01/02/2020 | |
Public Communications Contact | - | - | |
Corporate Officer/Principal | 01/02/2020 | 01/06/2021 |
Historial de carrera de Theresa Janke
Antiguos cargos conocidos de Theresa Janke.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Ignite Immunotherapy, Inc.
Ignite Immunotherapy, Inc. BiotechnologyHealth Technology Part of Pfizer Inc., Ignite Immunotherapy, Inc. is a company that designs and develops oncolytic virus vaccines. The company is based in New York, NY. The company was founded by David Schaffer, Douglas Hanahan, David H. Kirn, Theresa Janke, Melissa Kotterman. The CEO is Monika A. Vnuk. | Director/Miembro de la Junta | - | 01/10/2019 |
Fundador | - | 01/10/2019 | |
SILLAJEN, INC. | Corporate Officer/Principal | 01/01/2013 | 01/01/2014 |
CELGENE | Director Técnico/Científico/I+D | 01/01/2013 | 01/01/2014 |
SillaJen Biotherapeutics, Inc.
SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services SillaJen Biotherapeutics, Inc. develops and commercializes cancer therapeutics. It focuses on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for solid tumors. It is focused on two main programs, lead product candidate, which is in mid-stage clinical development for the treatment of advanced primary liver cancer and colorectal cancer and JX-929 which is under investigation for a variety of other solid tumors. The company was founded by John C. Bell and David H. Kirn in 2006 and is headquartered in San Francisco, CA. | Director Técnico/Científico/I+D | 01/01/2007 | 01/01/2013 |
Formación de Theresa Janke.
University of California, Santa Barbara | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 6 |
Corea del Sur | 2 |
Operativa
Founder | 2 |
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Sectorial
Health Technology | 5 |
Commercial Services | 2 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
4D MOLECULAR THERAPEUTICS, INC. | Health Technology |
SILLAJEN, INC. | Health Technology |
Empresas privadas | 3 |
---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
SillaJen Biotherapeutics, Inc.
SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services SillaJen Biotherapeutics, Inc. develops and commercializes cancer therapeutics. It focuses on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for solid tumors. It is focused on two main programs, lead product candidate, which is in mid-stage clinical development for the treatment of advanced primary liver cancer and colorectal cancer and JX-929 which is under investigation for a variety of other solid tumors. The company was founded by John C. Bell and David H. Kirn in 2006 and is headquartered in San Francisco, CA. | Commercial Services |
Ignite Immunotherapy, Inc.
Ignite Immunotherapy, Inc. BiotechnologyHealth Technology Part of Pfizer Inc., Ignite Immunotherapy, Inc. is a company that designs and develops oncolytic virus vaccines. The company is based in New York, NY. The company was founded by David Schaffer, Douglas Hanahan, David H. Kirn, Theresa Janke, Melissa Kotterman. The CEO is Monika A. Vnuk. | Health Technology |
- Bolsa de valores
- Insiders
- Theresa Janke
- Experiencia